GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Overview Fund Activity
Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

118 hedge funds and large institutions have $91.5M invested in Sanofi Contingent Value Rights in 2014 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 34 reducing their positions, and 14 closing their positions.

Holders
118
Holders Change
–
Holders Change %
0%
% of All Funds
3.15%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
%
% of All Funds
0.08%
New
15
Increased
13
Reduced
34
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
OAM
1
Oxford Asset Management
United Kingdom
$2.82M
2
LCM
2
Lonestar Capital Management
California
$1.03M
3
CPM
3
Chesapeake Partners Management
Maryland
$6.6M
4
FCM
4
Farmstead Capital Management
New Jersey
$364K
5
TI
5
Telemetry Investments
New York
$127K

Top Sellers

1
GCM
1
Gruss Capital Management
New York
$3.16M
2
NM
2
Newtyn Management
New York
$0
3
BPGAM
3
BTG Pactual Global Asset Management
Bermuda
$0
4
MCM
4
Mason Capital Management
New York
$11.6M
5
WA
5
Whitebox Advisors
Minnesota
$22.6M
Name Market Value Shares Shares
Change 		Shares
Change %
CHP
126
Cable Hill Partners
Oregon
$0 14 +14 New
AF
127
Arrow Financial
New York
$0 45 +45 New
BCM
128
Blume Capital Management
California
$0 50 +50 New
MFS
129
MSI Financial Services
Massachusetts
$0 288 +62 +27%
TCOV
130
Trust Company of Vermont
Vermont
$0 550 +150 +38%
DADC
131
D.A. Davidson & Co
Montana
$0 965 +200 +26%
LTFS
132
Ladenburg Thalmann Financial Services
Florida
$0 681 +200 +42%
2 3 4 5
6